Previous 10 | Next 10 |
The following slide deck was published by LivaNova PLC in conjunction with this event. For further details see: LivaNova (LIVN) Investor Day 2021 Presentation - Slideshow
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Goldman Sachs has initiated LivaNova (LIVN -1.0%) with a buy rating on the potential of its pipeline to drive shares higher. The firm has a price target of $108 (~31% upside). Analyst Amit Hazan says that catalysts in 2022 and later will "drive a revaluation higher over time." The first revie...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place December 3 – 7 in Chicago, Illinois. The Company will present seven scientific posters ...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4 th International Brain Stimulation Conference , taking place December 6 - 9 in Charleston, S.C. LivaNova will feature clinically meaningful developm...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald, Chief Executive Officer, will participate in discussions at the Piper Sandler 33 rd Annual Virtual Healthcare Conference on December 1, 2021. Meetings can be...
David Einhorn's 13F stock portfolio value decreased from $1.59B to $1.49B this quarter. Greenlight increased The ODP Group, LivaNova plc, and Sonos while reducing Concentrix and AerCap Holdings. The largest three positions are at ~44% of the portfolio. As of Q3 2021, the overall p...
The courts in Milan ruled that LivaNova would be liable for $519 million in damages in connection with a former parent company from Sorin with which it merged years ago. While they appeal the ruling, it really changes nothing in the LivaNova story which remains fully about the treatme...
LivaNova (LIVN -7.6%) has recorded the biggest intra-day loss since July 2020 in reaction to the company’s disclosure of a ruling by the Court of Appeal of Milan ((CoA)) where it was asked to pay damages to the tune of €453 million (nearly $519 million). In a civil action l...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, commented on the decision delivered today by the Court of Appeal of Milan (CoA) for LivaNova to pay damages in the amount of €453 million (approximately U.S. $519 million) as a result of a civ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...